Connexo – CBMG Partnership to Advance CBMG’s Quality Management System
HONG KONG – April 08, 2019 – Connexo, a leading provider of TrackWise QMS consulting/implementation services in Asia, has become the appointed QMS implementation partner to Cellular Biomedicine Group Inc (CBMG), a NASDAQ listed company in China that develops proprietary cell therapies for the treatment of cancer and degenerative diseases with operations in Shanghai headquarters and subsidiary offices in Beijing, Wuxi, Hong Kong and US.
On April 02, Connexo and CBMG had an official kickoff meeting that marked the beginning of the TrackWise implementation project in the Shanghai HQ. CBMG plans to introduce TrackWise QMS in its GMP facility in Shanghai with future roll-out plans to other locations towards embracing total quality compliance, thereby advancing its quality standards and accelerating time to market and greater business value for its customers in China and overseas.
“We are pleased to be awarded as the preferred QMS consulting and implementation partner to CBMG. Connexo’s subject matter expertise and decade-long experiences of QMS implementation for Asia’s largest pharmaceutical companies will help CBMG streamline and enhance their quality processes and get the best out of what TrackWise can offer” says Shawn Lee, CEO of Connexo.
“We are delighted to work with Connexo and their team of both local and overseas resources, which contributed overseas quality insights from a best business practice perspective, while at the same time, ensuring local support is always available. Their quick responses and accommodating style in catering to our changes has helped us to maximize our TrackWise usage and I’m confident we will go live as planned” says, Jack Li, Project Manager of CBMG.
Connexo is Asia’s No. 1 QMS consulting and implementation provider for life sciences in China, India and South Korea. To know more about our solutions and services, please visit here or contact us at email@example.com